RxDoctor Payments Data

Diamond Micielli

Family · Milton, DENPI 1184013757

Payments from drug & device makers

$2,107in general payments, 2019–2025

Across 117 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$386
  • Boehringer Ingelheim$365
  • Amgen$287
  • Novartis$215
  • Novo Nordisk$189
  • Johnson & Johnson$176
  • plus $489 from 14 others

What the payments were for

  • Food & beverage$2,07699%
  • Education$311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,107 in reported general payments places this provider in the 75th percentile of 523 family providers in Delaware.

See all family providers in Delaware

Medicare billing

Part B allowed, 2024
$118,079
Medicare patients
406
Services billed
1,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$65,255
EliquisApixaban33$44,702
JardianceEmpagliflozin31$33,914
XareltoRivaroxaban30$16,075
JanuviaSitagliptin Phosphate11$13,582
Spiriva RespimatTiotropium Bromide15$11,650
Atorvastatin Calcium331$3,607
Albuterol Sulfate HfaAlbuterol Sulfate96$3,199
Omeprazole169$2,816
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,754
Rosuvastatin Calcium135$2,018
SynthroidLevothyroxine Sodium23$1,880
Losartan Potassium156$1,848
Levothyroxine Sodium166$1,793
Metoprolol Succinate123$1,725

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$189$65,25546 claims
Boehringer IngelheimJardiance, Spiriva Respimat$365$45,56446 claims
PfizerEliquis$111$44,70233 claims
Johnson & JohnsonXarelto$176$16,07530 claims
MerckJanuvia$15$13,58211 claims
AbbVieSynthroid$23$1,88023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 523 family providers in Delaware.

Other family in Milton

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →